secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvation Bio Inc. (NUVB)
CIK:        0001811063
Form:       8-K
Filed at:   2026-07-06T21:15:46+00:00
Accession:  0001193125-26-296398
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.03, 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuvation Bio completes full greenshoe, raising $287.5M in convertible notes
---------------------------------------------------------------------------

- Underwriters exercised full over-allotment for additional $37.5M of 0.75% Convertible Senior Notes due 2032.
- Total aggregate principal amount of Notes sold: $287.5M; estimated net proceeds ~$277.6M.
- Net proceeds used to pay $2.2M for additional capped call transactions; remainder for general corporate purposes.
- Capped call transactions have cap price of $10.4580 per share, an 80% premium over June 25 closing price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811063/000119312526296398/0001193125-26-296398-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811063/000119312526296398/d136399d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-296398

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer